The Desmond Tutu
HIV Foundation

Pairing rigorous research with community-driven development, the DTHF is making a substantial contribution to service delivery and public health policy relating to HIV, tuberculosis and related infections in South Africa.

About Us Our People

HIV weekly news update in partnership with MedicalBrief

  • MEDICALBRIEF Issue No 209 – HIV News 21 May 2018

    Syringe programmes an important tool in preventing HIV outbreaks

    A US study found that a syringe services programme is an important tool to control and prevent HIV outbreaks among people who inject drugs in a non-urban area.
  • MEDICALBRIEF Issue No 209 – HIV News 21 May 2018

    Two-drug HIV regimen of DTG and 3TC effective in treatment-naive patients

    ViiV Healthcare has released data from two phase 3 trials that showed a once-daily, two-drug regimen of dolutegravir and lamivudine was non-inferior to a standard three-drug regimen in treatment-naive patients with HIV.
  • MEDICALBRIEF Issue No 209 – HIV News 21 May 2018

    Long periods of viral suppression reduces cancer risk in HIV population

    Early, sustained antiretroviral therapy (ART), which results in long-term viral suppression, helps to prevent Aids-defining cancers and also non-Aids-defining cancers, to a lesser degree.
  • MEDICALBRIEF Issue No 207 – HIV News 14 May 2018

    Online predictive computer models can optimise HIV therapy in patients failing treatment

    Predictive computer models designed to optimise HIV therapy in countries with limited healthcare resources have been published online. The models accurately predict how an individual on failing therapy will respond to any new combination of HIV drugs.
  • MEDICALBRIEF Issue No 207 – HIV News 14 May 2018

    Hepatitis B or raised liver enzymes predict liver toxicity with INH prophylaxis

    The risk of liver toxicity in people with HIV taking antiretroviral therapy and isoniazid preventive therapy for tuberculosis is strongly associated with either hepatitis B co-infection or pre-existing liver enzyme elevations, according to international research.
View All

Our Research


Women of Worth graduation

Graduation Day The Zimele project graduated their first group of participants from the Women of Worth programme in a ceremony …
Read More

Introducing the 2018-2019 Tutu PhD Candidate: Tracey Naledi

The Desmond Tutu HIV Centre and the Desmond and Leah Tutu Legacy Foundation are delighted to announce the 2018-19 Tutu …
Read More

17 May 2018: Conversations surrounding International Day Against Homophobia, Transphobia and Biphobia

On the 17th of May 2018, countries around the world will gather in celebration of the annual International Day Against Homophobia, Transphobia and Biphobia (IDAHOTB). This follows …
Read More

Results from innovative tuberculosis vaccine trial show potential for new BCG revaccination strategies and hope for subunit vaccines.

Scientists from the South African Tuberculosis Vaccine Initiative (SATVI) based at the University of Cape Town and the Desmond Tutu …
Read More

Our Projects

Desmond Tutu HIV Centre: Postgraduate Diploma in TB-HIV Medicine

Overview The Desmond Tutu HIV Centre and the University of Cape Town are proud to present the first online postgraduate …
Read More

The Tutu Tester

HIV and TB are managed successfully in many countries around the world. Yet, millions of people are still missing care. …
Read More

Adult HIV Educational Programme

Order a Manual Free Online Manual The aim of the HIV education programme is to improve the care of men …
Read More


Youth Centre
Youth Centre

The DTHF Youth Centre

The DTHF Youth Centre complex in Masiphumelele was built in response to requests from the community for a safe, recreational space for young people. DTHF surveys record a high prevalence of HIV infection among youth in the community.

Visit the Youth Centre